Patterns of response in patients with advanced melanoma treated with Pembrolizumab (MK-3475) and evaluation of immune-related response criteria (irRC)

Patterns of response in patients with advanced melanoma treated with Pembrolizumab (MK3475) and evaluation of immune-related response criteria (irRC) F Stephen Hodi, Antoni Ribas, Adil Daud, Omid Hamid, Caroline Robert, Richard Kefford, Wen-Jen Hwu, Tara C Gangadhar, Anthony M Joshua, Peter Hersey, Jeffrey Weber, Richard W Joseph, Hassane Zarour, Roxana Dronca, Linda Gammage, Darcy Hille, Dahai Xue, S Peter Kang, Patrick Chun, Scot W Ebbinghaus, Andrea Perrone, Jedd D Wolchok